These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1569569)

  • 1. Inhibition of beta-lactamase by clavulanate. Trapped intermediates in cryocrystallographic studies.
    Chen CC; Herzberg O
    J Mol Biol; 1992 Apr; 224(4):1103-13. PubMed ID: 1569569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.0 A resolution.
    Herzberg O
    J Mol Biol; 1991 Feb; 217(4):701-19. PubMed ID: 2005620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/intermediate of beta-lactam hydrolysis.
    Chen CC; Rahil J; Pratt RF; Herzberg O
    J Mol Biol; 1993 Nov; 234(1):165-78. PubMed ID: 8230196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of the acyl-enzyme complexes of the Staphylococcus aureus beta-lactamase mutant Glu166Asp:Asn170Gln with benzylpenicillin and cephaloridine.
    Chen CC; Herzberg O
    Biochemistry; 2001 Feb; 40(8):2351-8. PubMed ID: 11327855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clavulanate inactivation of Staphylococcus aureus beta-lactamase.
    Rizwi I; Tan AK; Fink AL; Virden R
    Biochem J; 1989 Feb; 258(1):205-9. PubMed ID: 2494991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.
    Reading C; Farmer T; Cole M
    J Antimicrob Chemother; 1983 Jan; 11(1):27-32. PubMed ID: 6600741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
    Brown RP; Aplin RT; Schofield CJ
    Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.
    Kuzin AP; Nukaga M; Nukaga Y; Hujer A; Bonomo RA; Knox JR
    Biochemistry; 2001 Feb; 40(6):1861-6. PubMed ID: 11327849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
    Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
    Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
    Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
    Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel fragments of clavulanate observed in the structure of the class A β-lactamase from Bacillus licheniformis BS3.
    Power P; Mercuri P; Herman R; Kerff F; Gutkind G; Dive G; Galleni M; Charlier P; Sauvage E
    J Antimicrob Chemother; 2012 Oct; 67(10):2379-87. PubMed ID: 22773738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX; McElrath MJ; Neu HC
    Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1.
    Chen CC; Smith TJ; Kapadia G; Wäsch S; Zawadzke LE; Coulson A; Herzberg O
    Biochemistry; 1996 Sep; 35(38):12251-8. PubMed ID: 8823158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
    Sun T; Bethel CR; Bonomo RA; Knox JR
    Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.
    Padayatti PS; Sheri A; Totir MA; Helfand MS; Carey MP; Anderson VE; Carey PR; Bethel CR; Bonomo RA; Buynak JD; van den Akker F
    J Am Chem Soc; 2006 Oct; 128(40):13235-42. PubMed ID: 17017804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the inactivation of the P54 mutant of beta-lactamase from Staphylococcus aureus PC1.
    Herzberg O; Kapadia G; Blanco B; Smith TS; Coulson A
    Biochemistry; 1991 Oct; 30(39):9503-9. PubMed ID: 1892849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.
    Knap AK; Pratt RF
    Biochem J; 1987 Oct; 247(1):29-33. PubMed ID: 2825657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.
    Lobkovsky E; Billings EM; Moews PC; Rahil J; Pratt RF; Knox JR
    Biochemistry; 1994 Jun; 33(22):6762-72. PubMed ID: 8204611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.